Jazz Pharmaceuticals plc 4

SVP Mary Elizabeth Henderson had 2,092 Jazz Pharmaceuticals ordinary shares disposed of to satisfy tax obligations from RSU vesting, leaving her with 25,242 shares owned.

On August 31, 2026, Mary Elizabeth Henderson, SVP, Technical Operations of Jazz Pharmaceuticals plc, had a small number of ordinary shares withheld or sold to cover tax obligations arising from the vesting of previously granted restricted stock units. Two Form 4 line items show tax-related dispositions coded as transaction type “F”: 2,076 ordinary shares at an implied price of $241.39 per share and 16 ordinary shares at an implied price of $244.6444 per share. These are routine, non‑discretionary transactions associated with equity compensation rather than open‑market buying or selling. Following these transactions, Henderson beneficially owned 25,242 ordinary shares of Jazz Pharmaceuticals, indicating a continuing, meaningful equity stake in the company.

Filing Facts

CIK

1232524

Ticker

JAZZ

Form

4

Source Type

fda

Accession

0001989533-26-000015

Alert Tier

4